Sanofi teams with non-profit on a landmark new drug for sleeping sickness
The EMA has offered its endorsement for fexinidazole, which is billed as the first all-oral drug for sleeping sickness.
The Drugs for Neglected Diseases …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
